TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Ascensia Diabetes Care Norway AS
Closing information (x1000 SEK)
| Closing information | 2025/03 | 2024/03 | 2023/03 |
| Turnover |
110,457
|
109,059
|
96,732 |
| Financial expenses |
21
|
44
|
214 |
| Earnings before taxes |
7,950
|
6,598
|
3,485 |
| Total assets |
52,659
|
50,927
|
57,645 |
| Current assets |
51,472
|
50,065
|
56,544 |
| Current liabilities |
34,932
|
31,257
|
25,465 |
| Equity capital |
13,546
|
19,045
|
31,670 |
| - share capital |
98
|
101
|
103 |
Financial ratios
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Solvency |
25.7%
|
37.4%
|
54.9% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
7.2%
|
6.0%
|
3.6% |
| Return on assets (ROA) |
15.1%
|
13.0%
|
6.4% |
| Current ratio |
147.3%
|
160.2%
|
222.0% |
| Return on equity (ROE) |
58.7%
|
34.6%
|
11.0% |
| Change turnover |
5,222
|
13,329
|
1,096 |
| Change turnover % |
5%
|
14%
|
1% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.